Epigenomics Ag
(ETR) ECX
Epigenomics Ag Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$448.00K
Net Income (TTM)
$16.29M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ECX News
ECX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Epigenomics Ag
Industry
Biotechnology
Sector
Health CareEmployees
34
CEO
Gregory K. Hamilton, MBA
Website
www.epigenomics.com/deHeadquarters
Berlin, 10829, DE
ECX Financials
Key Financial Metrics (TTM)
Gross Margin
75%
Operating Margin
-25%
Net Income Margin
-25%
Return on Equity
-74%
Return on Capital
-1%
Return on Assets
-76%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$365.00K
Operating Income
$12.05M
EBITDA
$11.22M
Operating Cash Flow
$12.02M
Capital Expenditure
$1.36M
Free Cash Flow
$13.39M
Cash & ST Invst.
$10.04M
Total Debt
$841.00K
Epigenomics Ag Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$70.00K
-44.4%
Gross Profit
$65.00K
-31.6%
Gross Margin
92.86%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
36
N/A
Net Income
$2.63M
-102.4%
EBITDA
$2.05M
-100.4%
Quarterly Fundamentals
Net Cash
$3.23M
-81.1%
Accounts Receivable
$331.00K
+60.7%
Inventory
$209.00K
+171.4%
Long Term Debt
$124.00K
-82.1%
Short Term Debt
$232.00K
-26.1%
Return on Assets
-75.85%
N/A
Return on Invested Capital
-1.12%
N/A
Free Cash Flow
$3.18M
-10.6%
Operating Cash Flow
$3.18M
-19.0%